The association of metabolic dysfunction-associated steatotic liver disease (MASLD) with the risk of myocardial infarction: a systematic review and meta-analysis

References

• Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):1–11. doi: 10.1002/hep.28431.
   Web of Science ®Google Scholar
• Eskridge W, Cryer DR, Schattenberg JM, et al. Metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: the patient and physician perspective. J Clin Med. 2023;12(19):6216.doi: 10.3390/jcm12196216.
   Web of Science ®Google Scholar
• Targher G, Byrne CD, Lonardo A, et al. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis. J Hepatol. 2016;65(3):589–600. doi: 10.1016/j.jhep.2016.05.013.
   PubMed Web of Science ®Google Scholar
• Yanai H, Adachi H, Hakoshima M, et al. Metabolic-dysfunction-associated steatotic liver disease-Its pathophysiology, association with atherosclerosis and cardiovascular disease, and treatments. Int J Mol Sci. 2023;24(20):15473. doi: 10.3390/ijms242015473.
   Web of Science ®Google Scholar
• Lekakis V, Papatheodoridis GV. Natural history of metabolic dysfunction-associated steatotic liver disease. Eur J Intern Med. 2023. doi: 10.1016/j.ejim.2023.11.005.
   Google Scholar
• Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med. 2010;363(14):1341–1350. doi: 10.1056/NEJMra0912063.
   PubMed Web of Science ®Google Scholar
• Del Ben M, Baratta F, Polimeni L, et al. Non-alcoholic fatty liver disease and cardiovascular disease: epidemiological, clinical and pathophysiological evidences. Intern Emerg Med. 2012;7 Suppl 3: s 291–296. doi: 10.1007/s11739-012-0819-4.
   Web of Science ®Google Scholar
• Lu H, Liu H, Hu F, et al. Independent association between nonalcoholic fatty liver disease and cardiovascular disease: a systematic review and meta-analysis. Int J Endocrinol. 2013;2013:124958–124957. doi: 10.1155/2013/124958.
   PubMed Web of Science ®Google Scholar
• Bhatia LS, Curzen NP, Calder PC, et al. Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor? Eur Heart J. 2012;33(10):1190–1200. doi: 10.1093/eurheartj/ehr453.
   Web of Science ®Google Scholar
• Wu S, Wu F, Ding Y, et al. Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: a systematic review and meta-analysis. Sci Rep. 2016;6(1):33386. doi: 10.1038/srep33386.
   PubMed Web of Science ®Google Scholar
• Lee HH, Lee HA, Kim EJ, et al. Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease. Gut. 2023;:gutjnl-2023-331003. doi: 10.1136/gutjnl-2023-331003.
   Web of Science ®Google Scholar
• Muzurović E, Peng CC-H, Belanger MJ, et al. Nonalcoholic fatty liver disease and cardiovascular disease: a review of shared cardiometabolic risk factors. Hypertension. 2022;79(7):1319–1326. doi: 10.1161/HYPERTENSIONAHA.122.17982.
   PubMed Web of Science ®Google Scholar
• Muzurović E, Polyzos SA, Mikhailidis DP, et al. Non-alcoholic fatty liver disease in children. Curr Vasc Pharmacol. 2023;21(1):4–25. doi: 10.2174/1570161121666221118155136.
   Web of Science ®Google Scholar
• Wang M, Zhou BG, Zhang Y, et al. Association between non-alcoholic fatty liver disease and risk of stroke: a systematic review and meta-analysis. Front Cardiovasc Med. 2022;9:812030. doi: 10.3389/fcvm.2022.812030.
   Web of Science ®Google Scholar
• Dulai PS, Singh S, Patel J, et al. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis. Hepatology. 2017;65(5):1557–1565. doi: 10.1002/hep.29085.
   PubMed Web of Science ®Google Scholar
• Stepanova M, Younossi ZM. Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population. Clin Gastroenterol Hepatol. 2012;10(6):646–650. doi: 10.1016/j.cgh.2011.12.039.
   PubMed Web of Science ®Google Scholar
• Ibanez B, James S, Agewall S, et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the european society of cardiology (ESC). Eur Heart J. 2018;39(2):119–177. doi: 10.1093/eurheartj/ehx393.
   PubMed Web of Science ®Google Scholar
• Han X, Bai L, Jeong MH, et al. Higher long-term mortality in patients with non-ST-Elevation myocardial infarction than ST-Elevation myocardial infarction after discharge. Yonsei Med J. 2021;62(5):400–408. doi: 10.3349/ymj.2021.62.5.400.
   Web of Science ®Google Scholar
• Kokkorakis M, Boutari C, Katsiki N, et al. From non-alcoholic fatty liver disease (NAFLD) to steatotic liver disease (SLD): an ongoing journey towards refining the terminology for this prevalent metabolic condition and unmet clinical need. Metabolism. 2023;147:155664. doi: 10.1016/j.metabol.2023.155664.
   Web of Science ®Google Scholar
• Méndez-Sánchez N, Bugianesi E, Gish RG, et al. Global multi-stakeholder endorsement of the MAFLD definition. Lancet Gastroenterol Hepatol. 2022;7(5):388–390. doi: 10.1016/S2468-1253(22)00062-0.
   PubMed Web of Science ®Google Scholar
• Li W, Ma D, Liu M, et al. Association between metabolic syndrome and risk of stroke: a meta-analysis of cohort studies. Cerebrovasc Dis. 2008;25(6):539–547. doi: 10.1159/000131672.
   Web of Science ®Google Scholar
• Schuch FB, Vancampfort D, Firth J, et al. Physical activity and incident depression: a meta-analysis of prospective cohort studies. Am J Psychiatry. 2018;175(7):631–648. doi: 10.1176/appi.ajp.2018.17111194.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–560. doi: 10.1136/bmj.327.7414.557.
   PubMed Web of Science ®Google Scholar
• Chen X, Lin X, Chen LD, et al. Obstructive sleep apnea is associated with fatty liver index, the index of nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol. 2016;28(6):650–655. doi: 10.1097/MEG.0000000000000598.
   Web of Science ®Google Scholar
• Lu Y, Wang Z, Zheng L. Association of smoking with coronary artery disease and myocardial infarction: a mendelian randomization study. Eur J Prev Cardiol. 2021;28(12):e11–e12. doi: 10.1177/2047487320907747.
   Web of Science ®Google Scholar
• Teo KK, Ounpuu S, Hawken S, et al. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet. 2006;368(9536):647–658. doi: 10.1016/S0140-6736(06)69249-0.
   PubMed Web of Science ®Google Scholar
• Hernaez R, Lazo M, Bonekamp S, et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology. 2011;54(3):1082–1090. doi: 10.1002/hep.24452.
   PubMed Web of Science ®Google Scholar
• Lee DH. Imaging evaluation of non-alcoholic fatty liver disease: focused on quantification. Clin Mol Hepatol. 2017;23(4):290–301. doi: 10.3350/cmh.2017.0042.
   PubMed Web of Science ®Google Scholar
• Labenz C, Huber Y, Michel M, et al. Impact of NAFLD on the incidence of cardiovascular diseases in a primary care population in Germany. Dig Dis Sci. 2020;65(7):2112–2119. doi: 10.1007/s10620-019-05986-9.
   PubMed Web of Science ®Google Scholar
• Oh H, Jun DW, Saeed WK, et al. Non-alcoholic fatty liver diseases: update on the challenge of diagnosis and treatment. Clin Mol Hepatol. 2016;22(3):327–335. doi: 10.3350/cmh.2016.0049.
   Google Scholar
• Luukkonen PK, Qadri S, Ahlholm N, et al. Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease. J Hepatol. 2022;76(3):526–535. doi: 10.1016/j.jhep.2021.10.013.
   PubMed Web of Science ®Google Scholar
• Valenzuela-Vallejo L, Mantzoros CS. Time to transition from a negative nomenclature describing what NAFLD is not, to a novel, pathophysiology-based, umbrella classification of fatty liver disease (FLD). Metabolism. 2022;134:155246. doi: 10.1016/j.metabol.2022.155246.
   Web of Science ®Google Scholar
• Shin S, Kim J, Lee JY, et al. Mitochondrial quality control: its role in metabolic dysfunction-associated steatotic liver disease (MASLD). J Obes Metab Syndr. 2023;32(4):289–302. doi: 10.7570/jomes23054.
   Google Scholar
• Ghoneim S, Dhorepatil A, Shah AR, et al. Non-alcoholic steatohepatitis and the risk of myocardial infarction: a population-based national study. World J Hepatol. 2020;12(7):378–388. doi: 10.4254/wjh.v12.i7.378.
   Web of Science ®Google Scholar
• Sinn DH, Kang D, Chang Y, et al. Non-alcoholic fatty liver disease and the incidence of myocardial infarction: a cohort study. J Gastroenterol Hepatol. 2020;35(5):833–839. doi: 10.1111/jgh.14856.
   Web of Science ®Google Scholar
• Xu J, Dai L, Zhang Y, et al. Severity of nonalcoholic fatty liver disease and risk of future ischemic stroke events. Stroke. 2021;52(1):103–110. doi: 10.1161/STROKEAHA.120.030433.
   Web of Science ®Google Scholar
• Chung GE, Cho EJ, Yoo JJ, et al. Young adults with nonalcoholic fatty liver disease, defined using the fatty liver index, can be at increased risk of myocardial infarction or stroke. Diabetes Obes Metab. 2022;24(3):465–472. doi: 10.1111/dom.14597.
   Web of Science ®Google Scholar
• Allen AM, Therneau TM, Mara KC, et al. Women with nonalcoholic fatty liver disease lose protection against cardiovascular disease: a longitudinal cohort study. Am J Gastroenterol. 2019;114(11):1764–1771. doi: 10.14309/ajg.0000000000000401.
   PubMed Web of Science ®Google Scholar
• Alexander M, Loomis AK, van der Lei J, et al. Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million european adults. BMJ. 2019;367:l5367. doi: 10.1136/bmj.l5367.
   PubMed Web of Science ®Google Scholar
• Gaggini M, Morelli M, Buzzigoli E, et al. Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease. Nutrients. 2013;5(5):1544–1560. doi: 10.3390/nu5051544.
   PubMed Web of Science ®Google Scholar
• Harrison SA, Gawrieh S, Roberts K, et al. Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort. J Hepatol. 2021;75(2):284–291. doi: 10.1016/j.jhep.2021.02.034.
   PubMed Web of Science ®Google Scholar
• Baratta F, Pastori D, Angelico F, et al. Nonalcoholic fatty liver disease and fibrosis associated with increased risk of cardiovascular events in a prospective study. Clin Gastroenterol Hepatol. 2020;18(10):2324–2331 e2324. doi: 10.1016/j.cgh.2019.12.026.
   PubMed Web of Science ®Google Scholar
• Bugianesi E, Moscatiello S, Ciaravella MF, et al. Insulin resistance in nonalcoholic fatty liver disease. Curr Pharm Des. 2010;16(17):1941–1951. doi: 10.2174/138161210791208875.
   Web of Science ®Google Scholar
• Byrne CD, Targher G. Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease: implications for cardiovascular disease. Arterioscler Thromb Vasc Biol. 2014;34(6):1155–1161. doi: 10.1161/ATVBAHA.114.303034.
   PubMed Web of Science ®Google Scholar
• Targher G, Corey KE, Byrne CD. NAFLD, and cardiovascular and cardiac diseases: factors influencing risk, prediction and treatment. Diabetes Metab. 2021;47(2):101215. doi: 10.1016/j.diabet.2020.101215.
   Web of Science ®Google Scholar
• Polyzos SA, Kechagias S, Tsochatzis EA. Review article: non-alcoholic fatty liver disease and cardiovascular diseases: associations and treatment considerations. Aliment Pharmacol Ther. 2021;54(8):1013–1025. doi: 10.1111/apt.16575.
   PubMed Web of Science ®Google Scholar
• Dixon JL, Ginsberg HN. Hepatic synthesis of lipoproteins and apolipoproteins. Semin Liver Dis. 1992;12(4):364–372. doi: 10.1055/s-2008-1040406.
   Web of Science ®Google Scholar
• Lisman T, Porte RJ. Pathogenesis, prevention, and management of bleeding and thrombosis in patients with liver diseases. Res Pract Thromb Haemost. 2017;1(2):150–161. doi: 10.1002/rth2.12028.
   PubMed Web of Science ®Google Scholar